Ipilimumab vs Methylphenidate
Ipilimumab vs Methylphenidate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylphenidate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Methylphenidate — Small molecule.